1. Clinical and pathological analyses of 14 cases of angiomatoid fibrous histiocytoma.
- Author
-
Zeng Q, Li JZ, Li GP, Chen YP, Song FL, and Gao F
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Aged, Child, Adolescent, Young Adult, Diagnosis, Differential, Desmin metabolism, Desmin genetics, Soft Tissue Neoplasms pathology, Soft Tissue Neoplasms genetics, Soft Tissue Neoplasms diagnosis, RNA-Binding Protein EWS genetics, Gene Rearrangement, Ki-67 Antigen metabolism, Ki-67 Antigen genetics, Biomarkers, Tumor genetics, Histiocytoma, Malignant Fibrous pathology, Histiocytoma, Malignant Fibrous diagnosis, Histiocytoma, Malignant Fibrous genetics
- Abstract
Angiomatoid fibrous histiocytoma (AFH) is a soft tissue tumor of uncertain differentiation. Although its prognosis is good, its diagnosis and differential diagnosis remain a challenge, particularly for tumors with an atypical morphology. We evaluated the clinicopathological characteristics of 14 AFH cases and examined the key factors in its diagnosis or differential diagnosis. The cohort comprised 6 men and 8 women aged 9-65 years (average age: 31.2 years). Most of the tumors (11/14, 79%) were located in soft tissues, whereas 3/14 (21%) were located in the lung (1 case) and brain (2 cases). Tumor cells were spindle-shaped to epithelioid, with a visible fibrous capsule (9/14, 64%), hemorrhagic gap (9/14, 64%), lymphocyte sleeve (7/14, 50%), necrosis (3/14, 21%), and infiltrative boundary (4/14, 29%). The tumors expressed desmin (10/14, 71%) and exhibited low levels of Ki-67. 13 cases (93%) displayed ESWSR1 gene rearrangement. At follow-up, 1 case (7%) experienced local tumor recurrence. AFH is a rare intermediate tumor. Its pathological diagnosis requires a comprehensive analysis of histological, immunophenotypic, and molecular genetic features to avoid misdiagnosis. Our study has further enriched the histological features of AFH, emphasizing the importance of differential diagnosis and providing a reference for clinical practice., (© 2024. The Author(s) under exclusive licence to The Japanese Society for Clinical Molecular Morphology.)
- Published
- 2024
- Full Text
- View/download PDF